13F HOLDINGS REPORT
Flagship Pioneering Inc.
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000950123-25-002708
Total Value
$334.2M
Positions
10
Other Managers
3
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 4,628,225 | $192.4M | 57.58% |
| 2 | Foghorn Therapeutics Inc | FHTX | 9,330,878 | $44.0M | 13.18% |
| 3 | Sana Biotechnology Inc | SANA | 15,909,178 | $25.9M | 7.76% |
| 4 | Omega Therapeutics Inc | 68217N105 | 22,240,723 | $16.6M | 4.96% |
| 5 | Foghorn Therapeutics Inc | FHTX | 3,343,242 | $15.8M | 4.72% |
| 6 | Sana Biotechnology Inc | SANA | 9,092,678 | $14.8M | 4.43% |
| 7 | Seres Therapeutics Inc | MCRB | 14,664,169 | $12.2M | 3.66% |
| 8 | Seres Therapeutics Inc | MCRB | 8,452,876 | $7.0M | 2.10% |
| 9 | Omega Therapeutics Inc | 68217N105 | 6,984,856 | $5.2M | 1.56% |
| 10 | Moderna Inc | MRNA | 3,924 | $163,160 | 0.05% |